SHR-4712

· Guangdong Hengrui Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR-4712, covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of SHR-4712 in Patients With Advanced Solid Tumors [Phase 1]